Linden Capital Partners Welcomes Gadi Lachman as Operating Partner
Chicago, Illinois (September 16, 2025) — Linden Capital Partners (“Linden”), a Chicago-based private equity firm focused exclusively on the healthcare sector, announced today that Gadi Lachman has joined the firm as an Operating Partner.
Mr. Lachman brings more than 20 years of leadership experience in healthcare technology and pharma services. Most recently, he served as Founder, Chief Executive Officer, and President of TriNetX, where he built the company into a global real-world data platform connecting more than 250 million patient records across 19 countries. Earlier in his career, Mr. Lachman held senior leadership roles at Amwell, Eliza Corporation, and TriZetto. He also served as an officer in the Israeli Special Forces.
“We are delighted to welcome Gadi to the team,” said Kam Shah, Partner at Linden. “With his exceptional track record as both a founder and strategic executive, and his success in scaling differentiated technology and data-driven businesses worldwide, Gadi is a valuable Operating Partner addition to Linden as we continue advancing technological innovation across healthcare business models.”
“I am honored to join Linden as an Operating Partner,” said Mr. Lachman. “Linden has a strong record of supporting healthcare businesses. I look forward to partnering with the team to pursue new opportunities in healthcare technology and pharma services and support the existing portfolio companies that can harness technology and data.”
Mr. Lachman earned his MBA with High Distinction (Baker Scholar) from Harvard Business School and holds an LL.B. in Law and a B.A. in Accounting from Tel Aviv University.
About Linden Capital Partners
Linden Capital Partners is a Chicago-based private equity firm focused exclusively on the healthcare industry. Founded in 2004, Linden is the largest dedicated healthcare private equity firm. Linden’s strategy is based upon three elements: (i) healthcare specialization, (ii) integrated private equity and operating expertise, and (iii) its differentiated human capital program. Since its founding, Linden has invested in over 45 healthcare companies encompassing over 350+ total transactions across its strategies. The firm currently manages over $13.0 billion of regulatory assets under management. For more information, please visit www.linden.com.